Pay in 4 interest-free payments of $6.82 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Januvia (Sitagliptin) Sales in 2022: $4.513 billion (includes sales of Janumet (sitagliptin + metformin)) Company/Developer: Merck Date of first FDA approval: October 16, 2006 Indications Januvia is FDA-approved for: Type 2 diabetes Price of Januvia: About $613 for a supply of 30 oral 100 mg tablets Why it did so well: Januvia is a dipeptidyl peptidase-4 (DPP-4) inhibitor indicated to improve glycemic control in patients with type 2 diabetes in conjunction with diet and exercise
Because this is a combination formula, increasing to two servings also doubles folate (to 1,000mcg) and vitamin D3 (to 2,000IU)
The available research shows the following: A retrospective cohort study by Burke et al
Use the peptide calculator to determine concentration based on your desired dose volume
Based on clinicaltrial.gov, the recruitment phase of a randomized study aimed to assess the efficacy of melatonin as an adjuvant in the treatment of free radicals in septic preterm infants compared to the conventional approach alone was completed in Egypt (NCT03295162)
Goss BD, Forman D, Ansell PE, Bennett V, Swerdlow AJ, Burge S, Ryan TJ
US$ 24.00
US$ 24.14
US$ 22.22
US$ 24.76
US$ 24.28
US$ 24.96
US$ 25.60
US$ 21.08
US$ 26.90
US$ 29.17
